Introduction
Indole (1), an electron-rich aromatic heterocyclic molecule (Nakai et al., 2003) , reacts with various kinds of electrophiles (Sundberg, 1996; Sala et al., 2002; Zolfigol et al., 2010; Shing et al., 2014) . The reactive pyrrole ring of indole (1) in Figure 1 with the relatively unreactive benzene ring can react with various kinds of electrophiles. In contrast to the accepted wisdom, the indole (1) nucleus has not been challenged to realize a nucleophilic substitution reaction (Yamada et al., , 2012 . In 1, electrophilic substitution is preferred in position 3 with almost all reagents including halogens (Tang et al., 2007) , nitrate (Gribble, 2003) , sulfur (Gilow et al., 1991) , Friedel-Crafts acyls (Ottoni et al., 2001) , and alkyls (Zhang et al., 2012) . Bromination of indole poses a dimeric product (2; Figure 1) ; as a result, 3-haloindoles and 2-haloindoles are unstable structures (Robertson et al., 2000; Joule and Mills, 2010; Kianmehr et al., 2012) . Since the dimeric structures can react with transition metals as ligands in order to give metal complexes, they have high potential for use in catalytic processes (Omura et al., 1977; Black, 1993; Saundane et al., 2013) .
N-containing heterocycles like azaindole and azanaphthalene ring systems are common moieties in a vast number of biologically active natural and unnatural compounds with pharmaceutically important molecules (Sundberg, 1996; Higasio and Shoji, 2001; Sala et al., 2002; Kawasaki and Higuchi, 2005; Şahin et al., 2012; . Biheterocycles like biindole (2) show a wide range of biological activities, and in many cases enhanced activity is observed compared to the single parent heterocycle (Hadden and Blagg, 2008) .
Some dimeric or substituted indole derivatives, such as indole-3-carbinol and its metabolic products, have been shown to be antiproliferative against various cancer lines such as breast, colon, hepatocellular, and prostate cell lines (Katdare et al., 1998; Chinni and Sarkar, 2002; Frydoonfar et al., 2002 Frydoonfar et al., , 2003 Hong et al., 2002; Howells et al., 2002; Zheng et al., 2002; Nachshon-Kedmi et al., 2003; Rahman et al., 2003; Weng et al., 2008; Ji et al., 2013; Parvatkar et al., 2013; Ali et al., 2014) . 3,3'-Diindolylmethane, a biindole derivative, can inhibit the growth and also the invasion of breast cancer, glioma, and nonsmall lung cancer cells (Rahimi et al., 2010) .
For this reason, heterocyclic compounds like indole constitute the framework of pharmacologically active compounds (Şahin et al., 2012; Ökten et al., 2013) , and we have studied the synthesis and anticancer potential of indole derivatives. In the current study, we investigated a method of synthesis for biindole (2) by using indole (1) treated with molecular bromine and determined its structure by 1D nuclear magnetic resonance (NMR) ( 1 H-NMR and 13 C-NMR) and 2D NMR (HETCOR, HMBC, NOESY, DEPT-90, and DEPT-135) techniques and elemental analysis. Furthermore, we have investigated antiproliferative activity of 2,3'-biindole (2) against HeLa, HT29, and C6 cell lines and its mechanism of action. Although 2 is a well-known compound, this is the first investigation revealing the antiproliferative and antitopoisomerase potential of 2 on several cancer cell lines in vitro. Revealing the anticancer potential of 2 may contribute to the investigation of a cure for cancer or therapy in the future.
Materials and methods
Thin layer chromatography was carried out on Merck silica F 254 0.255-mm plates, and spots were visualized by UV fluorescence at 254 nm. Classic column chromatography was performed using Merck 60 (70-230 mesh) silica gel. Melting point was determined on a ThomasHoover capillary melting point apparatus. Solvents were concentrated at reduced pressure. NMR spectra were recorded on a Bruker 400 MHz for 1 H-NMR and at 100 MHz for 13 C-NMR. IR spectrum was recorded on a JASCO 430 FT/IR instrument. Elemental analysis was recorded on an Elementar Vario MICRO Cube instrument.
Cell proliferation ELISA BrdU (colorimetric) kits were obtained from Roche Diagnostics GmbH (Mannheim, Germany). The antitumor drug 5-fluorouracil (5-FU) was purchased from Sigma. Other antiproliferative chemicals were used in analytical grade and obtained from SigmaAldrich, Merck, and Roche. 2.1. Synthesis of 2,3'-biindole (2) To a solution of indole (0.3 g, 2.56 mmol, 1 eq.) in CHCl 3 (25 mL), bromine solution (0.43 g, 1.28 mmol, 0.5 eq.) in CHCl 3 (5 mL) was added over 5 min. The mixture was stirred at room temperature for 20 min in the dark. After completion of the reaction, the resulting dark solution was washed with 5% NaHCO 3 solution (3 × 15 mL) and dried over Na 2 SO 4 . The solvent was removed, and the crude product was passed through a short silica gel (5 g) column eluted with hexane-AcOEt (6/1) to yield a pale brown solid (0.24 g, 82%). NMR analysis (Figures S1-S8 on journal's website; Table) of the product showed the formation of 2. Mp: 203-204 °C (lit Bocci and Palla, 1984 , 203-205 °C 109.0, 110.9, 112.4, 119.3, 119.6, 120.1, 120.3, 120.8, 122.2, 123.6, 125 
Cell culture and cell proliferation assay
HeLa (human cervix carcinoma), HT29 (human colon carcinoma), and C6 (rat brain tumor) cell lines were grown in Dulbecco's Modified Eagle Medium (DMEM; Sigma), supplemented with 10% (v/v) fetal bovine serum (Sigma) and PenStrep solution (Sigma) at 37 °C in a 5% CO 2 humidified atmosphere. For the proliferation assay, cells were plated in 96-well culture plates (COSTAR, Corning, USA) at a density of 30,000 cells per well. Stock solution of the 2,3'-biindole (2) and 5-FU were solved in DMSO and diluted with DMEM. The final concentration of DMSO was below 0.5% in all tests. The vehicle (DMSO), 5-FU, and the samples at various concentrations (0-100 µg/mL) were added to each well.
Cells were then incubated overnight before applying the BrdU cell proliferation ELISA assay reagent (Roche) according to the manufacturer's procedure. Briefly, cells were pulsed with BrdU labeling reagent for 4 h followed by fixation in FixDenat solution for 30 min at room temperature. Thereafter, cells were incubated with a 1:100 dilution of anti-BrdU-POD for 1.5 h at room temperature. The amount of cell proliferation was assessed by determining the 450 nm value of the culture media after the addition of substrate solution using a microplate reader (RAYTO RT2100C, China). Results were reported as percentage of inhibition of cell proliferation, where the optical density measured from vehicle-treated cells was 100% of proliferation. Percentage inhibition of cell proliferation was calculated as follows: [1 -(A treatments / A vehiclecontrol )] × 100. Percent inhibition was reported as mean value ± SEM of 3 independent assays.
Cytotoxic activity assay
The cytotoxic activities of 2,3'-biindole (2) and the control compound were tested using the LDH Cytotoxicity Detection Kit (Roche) based on the detection of lactate dehydrogenase (LDH) activity released from the cells into the supernatant, according to the manufacturer's instructions. Briefly, 3 × 10 4 cells in 100 µL were seeded into 96-well microtiter plates as triplicates and treated with an IC 50 concentration of 2 at 37 °C with 5% CO 2 overnight. LDH activity was determined by measuring absorbance at 492-630 nm using a microplate reader (RAYTO RT2100C). Percentage cytotoxicity was calculated as follows: cytotoxicity (%) = [(experimental value -low control) / (high control -low control)] × 100.
DNA laddering assay
The DNA laddering effect of the test compounds was measured according to the method of Gong et al. (1994) with some modifications. Briefly, 7.5 × 10 5 cells were seeded into 25-cm 2 culture flasks and treated with IC 50 concentrations of C1 and C2 at 37 °C with 5% CO 2 overnight. Treated cells were harvested using a sterile plastic scraper, transferred to a 15-mL sterile Falcon tube, washed with 1 mL of sterile DPBS, and pelleted by spinning at 1500 × g for 5 min. The cell pellet was resuspended with 200 µL of ice-cold DPBS by gently pipetting and then fixed with 5 mL of ice-cold 70% ethanol, vortexed briefly, and incubated at -20 °C for 24 h. The cells were centrifuged at 1500 × g for 5 min, the supernatant was removed, and the remaining ethanol was removed by air drying. The cell pellet was resuspended in 50 µL of phosphate-citrate buffer (consisting of 192 parts 0.2 M Na 2 HPO 4 and 8 parts 0.1 M citric acid, pH 7.8), incubated at 37 °C for 30 min in a shaker incubator, and centrifuged at 1500 × g for 5 min. Next, 40 µL of supernatant was transferred to a 1.5-mL microcentrifuge tube, mixed with 5 µL of Tween 20 solution (0.25% in ddH 2 O) and 5 µL of RNase A solution, and incubated at 37 °C for 30 min in a shaker incubator. Then 5 µL of proteinase K was added to each tube and tubes were incubated at 37 °C for 10 min. Eventually, the content of the microcentrifuge tube was mixed with 4 µL of 6X loading buffer, loaded to 1.5% agarose gel containing 0.5 µg/mL ethidium bromide (EtdBR), and electrophoresed at 200 mA for 40 min. DNA fragmentation in the gels was visualized using a gel documentation system (UVP, UK).
Topoisomerase I assay
The DNA topoisomerase I activity of 2 was determined by testing the relaxation of supercoiled plasmid DNA (pHOT) using a topoisomerase I assay kit (TopoGEN, Inc., USA). A mixture containing 0.25 µg of the plasmid pHOT DNA and 1-2 units of recombinant human DNA topoisomerase I (TopoGEN) was incubated with an IC 50 concentration of 2 (test) or EtdBr (positive control). No enzyme was added for the negative control. All reactions were incubated in the reaction buffer (10 mM Tris-HCl, pH 7.9; 1 mM EDTA; 0.15 M NaCl; 0.1% BSA; 0.1 mM spermidine; 5% glycerol) at 37 °C for 30 min. Reactions were terminated with 5 µL (per 20 µL of reaction volume) of stop buffer (5% sarkosyl, 0.0025% bromophenol blue, 25% glycerol). Reaction products were analyzed on 1% agarose gel at 60 V for 1.5 h. The gels were stained with EtdBr for 10 min, destained with water for 20 min after electrophoresis, and visualized using a gel documentation system (UVP).
Statistical analysis
The results of in vitro proliferation assays are the means ± SEMs of 2 individual experiments; a total of 6 measurements were performed for each cell type. Differences between treatment groups were tested by 2-way ANOVA, and P-values of 0.05 were considered significant.
Results

Synthesis of biindole (2)
A variety of methods have been reported for the synthesis of 2 and its derivatives (Bergman, 1973; Bergman and Eklund, 1980; Bocchi and Palla, 1982 , 1983 , 1984 Saito et al., 1982; Robertson et al., 2000; Wahlström et al., 2007; Dupeyre et al., 2011) . The reaction of indole with molecular bromine yielded a pale brown solid (82%). Facile one-step synthesis of 2 was achieved by bromination of indole (1), which underwent simultaneous dimerization (Figure 2 ). The preparation of the asymmetric dimer structure (2) shows a mechanism that is likely to yield 3-bromoindole (3), as 3 can react with another molecule of indole to provide coupling in a 2,3-manner (Bocchi and Palla, 1982; Robertson et al., 2000) . The structure of 2 was identified by 1D and 2D NMR techniques (HETCOR, HMBC, and NOESY) and multiple-pulse NMR experiments (DEPT-90 and DEPT-135). NMR spectra are available in the supplementary figures. The DEPT-135 spectra ( Figure S5 ) of 2 revealed signals at δ C 109.0, 134.6, which were assigned quaternary carbons of C-3' and C-2, respectively. In HMBC spectra ( Figure S6 ), the one from the quaternary C atom at C-2 (δ C 134.6) correlated with 2 singlet protons, H-3 (δ H 6.80) and H-2' (δ H 7.91), while C-3' (δ C 109.0) correlated with H-3 (δ H 6.80), H-2' (δ H 7.91), and C-4' (δ C 8.04). In addition, the signal at δ C 123.6 did not correlate with any protons, indicating that it belonged to C-2' . The NOESY ( Figure S7 ) and HETCOR ( Figure S8 ) experiments also supported this evidence. In NOESY spectra ( Figure S7 ), correlation was observed between H-3 (δ H 6.80), H-4 (δ H 7.54), and H-4' (δ H 8.04). The signal at δ C 97.3 correlated with a singlet (δ H 6.80) in the HETCOR ( Figure S8 ) experiment as well as 2 doublets (δ H 7.00, 7.54) in the HMBC (Figure S6 ) experiment. These results indicated that singlet (δ H 6.80) and doublet (δ H 7.54, 7.00) protons were at C-3, C-4, and C-5, respectively. Long-range couplings between signals observed in 13 C-NMR ( Figure S3 ) and 1 H-NMR (Figures S1 and S2) spectra were explained by HMBC (Figure S6 ) experiments. The HMBC cross peaks between methine protons and carbons showed that methine groups (δ H 6.80, 7.91, 8.04 ) and quaternary carbon (δ C 109.0) were at C-3, C-2' , C-4' , and C-3' , respectively. A doublet at δ H 7.54 at C-4 correlated to δ H 7.00 at C-5 and δ H 6.80 singlet at C-3; a singlet at 11.23 (NH) correlated to 7.91 at C-2' and 7.41 at C-7; and another singlet 11.44 (NH) correlated to 7.91 at C-2' and 7.51 at C-7' in the NOESY ( Figure S7 ) experiment. All NMR data (Figures S1-S7) support the proposed structure (2).
Antiproliferative activity of 2,3'-biindole (2) against HeLa, HT29, and C6 cell lines
The antiproliferative activity of 2 against HeLa, HT29, and C6 cell lines was investigated using the BrdU cell proliferation ELISA assay (Roche) at several concentrations. In contrast to the 5-FU control used as a cancer drug, 2 significantly inhibited (P < 0.05) proliferation of HeLa, HT29, and C6 cell lines at especially high concentrations (30-75 µg/mL and 50-75 µg/mL, respectively) ( Figures  3A-3C ).
3.3. Effect of 2,3'-biindole (2) on the morphology of HeLa, HT29, and C6 cell lines Treatment of cells with 2 led to blebbing, disruption, and disintegration of cells in general, indicating its cytotoxic effect. At high concentrations, 2 caused cell detachment from the plate surface (Figure 4) .
Cytotoxic activity of 2,3'-biindole (2) on HeLa, HT29, and C6 cell lines
Cytotoxic activity of 2 on HeLa, HT29, and C6 cell lines was determined using the LDH Cytotoxicity Detection Kit (Roche) at IC 50 concentrations. Results showed that the cytotoxic activity of 2 was lower on HT29 cell lines and higher on HeLa and C6 cells lines than that of 5-FU (P < 0.05) (Figure 5 ).
Apoptotic potential of 2,3'-biindole (2)
Apoptotic potential of 2 on C6 and HeLa cell lines was investigated using a DNA fragmentation assay at its IC 50 concentration. In this study, SO22, an apoptotic quinoline derivative (Köprülü et al., 2013) , was used as a positive control because the apoptotic action of SO22 is higher than that of camptothecin, a quinoline alkaloid used for apoptotic potential studies. Although 2 induced DNA fragmentation at a very low level, especially on C6 cell lines, camptothecin did not induce fragmentation of cell DNA that was as high as SO22 (Figure 6 ). Therefore, we suggest that the antiproliferative activity of 2 may not involve induction of apoptosis in general. 
Antitopoisomerase activity of 2,3'-biindole (2)
To understand if antiproliferative activity of 2 involves inhibition of topoisomerases, we tested the antitopoisomerase activity of compound 2 using a TOPO isomerase I assay kit (TopoGEN). Results showed that compound 2 inhibited topoisomerase activity as the positive control, EtdBr (Figure 7 ).
Discussion
The antiproliferative activity of some substituted indole and biindole derivatives against breast, colon, and lung cancer cells has been reported (Katdare et al., 1998; Chinni and Sarkar, 2002; Frydoonfar et al., 2002 Frydoonfar et al., , 2003 Hong et al., 2002; Howells et al., 2002; Zheng et al., 2002; Hudson et al., 2003; Nachshon-Kedmi et al., 2003; Rahman et al., 2003; Weng et al., 2008; Ji et al., 2013; Ali et al., 2014) . The antiproliferative and cytotoxic activities of 2 against HeLa, C6, and HT29 cell lines were tested and documented for the first time in this study. We compared the antiproliferative activity of 2 with a known anticancer drug, 5-FU, which has strong antiproliferative activity in various tumor cell lines (Chen et al., 1995; Ferguson et al., 1999; Ahmed and Jamil, 2011) . We found that 2 was as antiproliferative against tumor cell lines HeLa, C6, and HT29 as 5-FU (Figures 3-5) . Compound 2 was more antiproliferative against HeLa and HT29 cell lines than C6 cell lines at higher concentrations (30-75 µg/mL) (Figures 3 and 4) . These results were similar to previous studies done with indole and biindole derivatives (Katdare et al., 1998; Frydoonfar et al., 2002 Frydoonfar et al., , 2003 Hong et al., 2002; Howells et al., 2002; Rahman et al., 2003; Weng et al., 2008; Ji et al., 2013; Ali et al., 2014) . We also tested the cytotoxic activity of 2 on HeLa, C6, and HT29 cell lines. Cytotoxicity of 2 was low on HT29 cell lines and high on HeLa and C6 cell lines. The blebbing, disruption, and disintegration of HeLa, HT29, and C6 cell lines treated with 2 somewhat proved the cytotoxicity (Figure 4) . Moreover, DNA laddering assay results showed that 2 did not induce DNA fragmentation in cells tested, indicating that it may act through a mechanism other than apoptosis. In addition, as EtdBr, compound 2 inhibited relaxation of supercoiled plasmid DNA by topoisomerase I activity, suggesting that compound 2 may act by inhibiting topoisomerase I action to inhibit cell proliferation.
In conclusion, our present work demonstrated that the potential anticancer compound 2 worked on C6 (rat brain tumor), HeLa (human cervix carcinoma), and HT29 (human colon carcinoma) cells lines via inhibiting proliferation of those cell lines and topoisomerase activity. However, further in vitro and in vivo investigations are needed to reveal the anticancer potential and mechanism of action of 2. Figure S5 . DEPT-135 spectrum of 2,3'-biindole (2). Figure S6 . HMBC spectrum of 2,3'-biindole (2).
